What question did this study set out to answer?

To calculate BMI-adjusted circulating leptin concentrations across acute and recovered eating disorders and assess their viability as disease-specific biomarkers.

December 6, 2024European Eating Disorders ReviewOpen Access

Leptin Levels in Acute and Recovered Eating Disorders: An Arm‐Based Network Meta‐Analysis

View Full Paper

Ask AI

Bookmark

Authors

ECEmanuele CassioliAzienda Ospedaliero-Universitaria Careggi LALorenzo Lucherini AngelettiRoyal Ottawa Mental Health Centre EREleonora RossiNational Center for Oncological Hadrontherapy

Discussion

Member takes

Implication

Network meta-analysis reveals significant BMI-independent leptin alterations across eating disorders, suggesting leptin's potential utility as a clinical biomarker for disease staging.

Key Points

To calculate BMI-adjusted circulating leptin concentrations across acute and recovered eating disorders and assess their viability as disease-specific biomarkers.
Systematic search of PubMed and ClinicalTrials.gov identifying 146 studies comprising 5,048 patients with eating disorders and 3,525 healthy controls.
Multilevel network meta-analysis conducted using a linear mixed-effects meta-regression model adjusting for BMI, sex, and assay type.
Patients with anorexia nervosa exhibited the lowest leptin levels, whereas those with binge eating disorder demonstrated the highest levels.
Individuals with bulimia nervosa and recovered anorexia nervosa exhibited leptin concentrations significantly lower than healthy controls and comparable to acute anorexia nervosa.
Differences across diagnostic groups remained statistically significant after adjusting for BMI, sex, and assay type.

Cite This Study

Cassioli et al. (2024) studied this question.

synapsesocial.com/papers/6a70e1baa528af2d65c3cb9f https://doi.org/10.1002/erv.3163

View Full Paper

Ask AI

Bookmark

Implication

Network meta-analysis reveals significant BMI-independent leptin alterations across eating disorders, suggesting leptin's potential utility as a clinical biomarker for disease staging.

Leptin Levels in Acute and Recovered Eating Disorders: An Arm‐Based Network Meta‐Analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Leptin Levels in Acute and Recovered Eating Disorders: An Arm‐Based Network Meta‐Analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider